| The role of TLR2 in infection and immunity L Oliveira-Nascimento, P Massari, LM Wetzler Frontiers in immunology 3, 79, 2012 | 928 | 2012 |
| Cutting edge: Immune stimulation by neisserial porins is toll-like receptor 2 and MyD88 dependent P Massari, P Henneke, Y Ho, E Latz, DT Golenbock, LM Wetzler The Journal of Immunology 168 (4), 1533-1537, 2002 | 410 | 2002 |
| The role of porins in neisserial pathogenesis and immunity P Massari, S Ram, H Macleod, LM Wetzler Trends in microbiology 11 (2), 87-93, 2003 | 251 | 2003 |
| Immunology, infection, and immunity GB Pier, JB Lyczak, LM Wetzler Immunology, infection, and immunity, 718-718, 2004 | 236 | 2004 |
| Neisseria meningitidis porin PorB interacts with mitochondria and protects cells from apoptosis P Massari, Y Ho, LM Wetzler Proceedings of the National Academy of Sciences 97 (16), 9070-9075, 2000 | 227 | 2000 |
| The role of Toll-like receptor 2 in microbial disease and immunity LM Wetzler Vaccine 21, S55-S60, 2003 | 222 | 2003 |
| The contrasting mechanisms of serum resistance of Neisseria gonorrhoeae and group B Neisseria meningitidis S Ram, FG Mackinnon, S Gulati, DP McQuillen, U Vogel, M Frosch, ... Molecular Immunology 36 (13-14), 915-928, 1999 | 208 | 1999 |
| Meningococcal porin PorB binds to TLR2 and requires TLR1 for signaling P Massari, A Visintin, J Gunawardana, KA Halmen, CA King, ... The Journal of Immunology 176 (4), 2373-2380, 2006 | 202 | 2006 |
| Gonococcal lipooligosaccharide sialylation prevents complement-dependent killing by immune sera LM Wetzler, K Barry, MS Blake, EC Gotschlich Infection and immunity 60 (1), 39-43, 1992 | 189 | 1992 |
| Cutting edge: MyD88 controls phagocyte NADPH oxidase function and killing of gram-negative bacteria FS Laroux, X Romero, L Wetzler, P Engel, C Terhorst The Journal of Immunology 175 (9), 5596-5600, 2005 | 173 | 2005 |
| Macrophage-specific TLR2 signaling mediates pathogen-induced TNF-dependent inflammatory oral bone loss G Papadopoulos, EO Weinberg, P Massari, FC Gibson, LM Wetzler, ... The Journal of Immunology 190 (3), 1148-1157, 2013 | 171 | 2013 |
| Neisserial porins induce B lymphocytes to express costimulatory B7-2 molecules and to proliferate. LM Wetzler, Y Ho, H Reiser, LW Wetzler The Journal of experimental medicine 183 (3), 1151-1159, 1996 | 143 | 1996 |
| Gonococcal Porin Vaccine Evaluation: Comparison of Por Proteosomes, Liposomes, and Blebs Isolated from rmp Deletion Mutants LM Wetzler, MS Blake, K Barry, EC Gotschlich Journal of Infectious Diseases 166 (3), 551-555, 1992 | 133 | 1992 |
| Neisserial porin-induced dendritic cell activation is MyD88 and TLR2 dependent TE Singleton, P Massari, LM Wetzler The Journal of Immunology 174 (6), 3545-3550, 2005 | 130 | 2005 |
| T cell activation by TLRs: a role for TLRs in the adaptive immune response H MacLeod, LM Wetzler Science's STKE 2007 (402), pe48-pe48, 2007 | 124 | 2007 |
| Neisserial porins inhibit human neutrophil actin polymerization, degranulation, opsonin receptor expression, and phagocytosis but prime the neutrophils to increase their … R Bjerknes, HK Guttormsen, CO Solberg, LM Wetzler Infection and immunity 63 (1), 160-167, 1995 | 114 | 1995 |
| Neisserial PorB is translocated to the mitochondria of HeLa cells infected with Neisseria meningitidis and protects cells from apoptosis P Massari, CA King, AY Ho, LM Wetzler Cellular microbiology 5 (2), 99-109, 2003 | 109 | 2003 |
| Lipid-mediated targeting with membrane-wrapped nanoparticles in the presence of corona formation F Xu, M Reiser, X Yu, S Gummuluru, L Wetzler, BM Reinhard ACS nano 10 (1), 1189-1200, 2016 | 85 | 2016 |
| Early administration of interleukin-6 inhibitors for patients with severe COVID-19 disease is associated with decreased intubation, reduced mortality, and increased discharge P Sinha, A Mostaghim, CG Bielick, A McLaughlin, DH Hamer, LM Wetzler, ... International Journal of Infectious Diseases 99, 28-33, 2020 | 83 | 2020 |
| Immunologic memory induced by a glycoconjugate vaccine in a murine adoptive lymphocyte transfer model HK Guttormsen, LM Wetzler, RW Finberg, DL Kasper Infection and immunity 66 (5), 2026-2032, 1998 | 81 | 1998 |
